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Enzootic bovine leukosis is a contagious disease of cattle caused by the retrovirus, bovine leukemia virus (BLV) and is the most
common cause of malignant neoplasm in cattle. In order to facilitate surveillance of this disease in dairy herds, we developed
a method to combine ELISA of milk collected during routine production testing with a prescribed sampling of cows that is
independent of the proportion of cows within each lactation. In 113 Michigan dairy herds, milk samples from ten cows in each
of the 1st, 2nd, 3rd, and ≥4th lactations were analyzed for anti-Bovine Leukemia Virus (BLV) antibodies by milk ELISA. For each
herd, a BLV herd proﬁle (BHP) was calculated as the simple average of the percent of BLV-positive cows within each of the four
lactation groups. The mean BHP for all herds was 32.8%, with means of 18.5, 28.8, 39.2, and 44.8% of 1st, 2nd, 3rd, and ≥4th
lactation animals infected, respectively. In eight herds, we determined the correlation between the BHP, and true herd prevalence
by testing the entire lactating herd (r = 0.988, P<0.0001). The BHP allows discrimination of lactation-speciﬁc BLV prevalence
within a dairy herd, to help identify risk factors and management plans that may be important in transmission of BLV.
1.Introduction
Enzootic bovine leukosis is a contagious disease of cattle
induced by the Δ-retrovirus, bovine leukemia virus (BLV).
The disease complex is characterized by a persistent lympho-
cytosis which can culminate in B-cell lymphoma. Although
BLV-induced lymphoma is the most common neoplastic
disease of cattle, most infected cows do not display outward
signs of disease, and these animals are referred to as asymp-
tomatic or aleukemic [1]. Approximately 30–40% of BLV
carriers will develop a persistent lymphocytosis while fewer
than 5% develop malignant lymphosarcoma [1]. Surveys
from geographic locations other than Europe have reported
within-herd prevalence of BLV in adult dairy cattle from 23
to 46% [2–5].
Infection of BLV, as detected by serology, is more typical
of older cattle as opposed to younger cattle [1, 6], and in one
large California dairy, prevalence was reported to increase
from 43% in ﬁrst lactation cows to 72% in second lactation
cows [7]. The eﬀect of age distribution on herd-level BLV
prevalence is so strong that diﬀerences between herds in
the proportion of cows in various lactations confound
any interherd comparisons of BLV prevalence. This study
investigates the use of a BLV herd proﬁle (BHP) to determine
parity-related herd BLV prevalence, independent of the pro-
portion of cows within each lactation, using a commercially
available milk ELISA test. This approach provides a novel,
economical, and practical method to determine herd-level
BLV infection status, stratiﬁed by lactation, which can help
evaluate transmission risk factors and suggest management
strategies for control of BLV within a dairy herd.
2.MaterialsandMethods
2.1. Herd Selection. Dairy herds in Michigan, that rou-
tinely participated in Dairy Herd Improvement Association
(DHIA) testing, and averaged ≥120 cows on test for the
previous 12 months, were stratiﬁed into equal-sized cohorts2 Veterinary Medicine International
of 119 small-sized herds (120–174 cows), 119 medium-sized
herds(175–295cows),and119largeherds(298–6,738cows).
Within each of these strata, herds were assigned a random
number which determined the order in which they were
contacted and invited to participate in our study. Forty herds
were sought from each cohort, but exclusions because of the
inability to schedule herd visits, or lack of data within herd
DHIA records, resulted in a total of 113 participating herds.
The mean (±SEM) number of cows on test for each herd was
407.7 ±67.0,andrangedfrom113to6,492.105herdsmilked
Holstein cows only, 2 herds Brown Swiss, 4 herds Jerseys, and
2 herds milked a mixture of breeds.
2.2. Selection of Cows for Sampling. In order to estimate the
number of cows to be sampled per herd, we calculated, by
binomial proportion of standards, that if the true within-
herd prevalence was 10%, there would be a 5% probability
that no positive cows would be among a sample of 28 cows,
that is, the probability was 95% that we would ﬁnd at least
one positive cow. We selected the theoretical BLV prevalence
of 10% for our calculations because this is well below the
mean herd prevalence reported in several studies [2–5], and
thus tried to account for the diﬃculty to detect infected
cows in herds with low prevalence. In order to improve
precision, and account for attrition from the time of cow
selection until actual milk sample collection, the targeted
sample size per herd was increased to 40 cows. Thus, within
each herd, we identiﬁed 10 cows each from the ﬁrst, second,
third, and ≥fourth lactations that were the most recently
calved, based on current DHIA test. On the next test day for
each herd, (June through August, 2010) DHIA technicians
collected milk samples from the surviving selected cows
for submission to the laboratory (Antel BioSystems, Inc.,
Lansing, MI) for ELISA testing of BLV antibodies.
2.3.CalculationandValidationoftheBLVHerdProﬁle(BHP).
For each of the 113 herds, the percent of BLV-positive cows
was computed for each lactation group and the percentages
from all four lactation groups were averaged (with equal
weight)tocalculatetheBHP.Inordertovalidatetheaccuracy
of the BHP sampling relative to total herd BLV prevalence,
we stratiﬁed all 113 herds by BHP result in quartiles (very
low prevalence, lower than average prevalence, above average
prevalence, and very high prevalence) and randomly selected
twoherds fromeach quartile forfurtherBLVtesting. In these
8 herds, milk samples were collected from all lactating cows
for BLV ELISA (n = 2,158) to calculate BHP (based on
40 cows). The BHP was then compared to the average of
lactation-speciﬁc prevalence (from whole-herd testing) and
total herd prevalence by simple correlation analysis.
2.4. BLV ELISA. Milk samples were immediately preserved
with 0.2mg/mL bronopol and 7.8µg/mL natamycin (D&F
Control Systems, Inc., Dublin, CA). Samples were trans-
ported to a DHIA laboratory (Universal Laboratory Services,
East Lansing, MI) and subsequently analyzed for antibodies
to BLV as described below (Antel BioSystems, Inc., Lansing,
MI). All transportation and storage of samples was at
ambienttemperature.AllanalysesforantibodiestoBLVwere
conducted within 5 days of the original collection date.
We previously determined that the stability of anti-Myco-
bacterium avium subsp. paratuberculosis antibodies in milk,
stored,anddetectedbyacommercialassaysimilartothemilk
BLV ELISA, is consistent for 14 days at room temperature
(Byrem, unpublished data). Antibodies to BLV were detected
using an ultrapure virus lysate in a commercially available
antibody capture ELISA (IDEXX Laboratories, Westbrook,
Maine) routinely used for bulk milk analysis. Prior to
analysis, individual DHIA milk samples were diluted 1:30 in
sample diluent to reduce the eﬀect of carryover contamina-
tion (<1%) that occurs during the DHIA sampling process.
Brieﬂy for the ELISA, antibodies to BLV in dilute milk sam-
ples bind to microtiter plate wells previously coated with
virus lysate. Bound antibodies from milk are detected by
reaction with horseradish-peroxidase-(HRP-) labeled mon-
oclonal antibodies to bovine immunoglobulin (IgG). Bound
HRP-labeled antibodies are detected by addition of enzyme
substrate. Reaction times are standardized to the color devel-
opment of positive controls (0.9 < 450nm OD < 1.2) and
stoppedbytheadditionof0.5NH2SO4.Samplesc or es(sam-
ple OD-negative control OD) ≥0.1 were considered positive.
2.5. Statistical Analysis. Correlations among herd measures
of BLV prevalence were expressed as Pearson correlation
coeﬃcients(r).BLVprevalenceratesamonglactationgroups
were evaluated with one-way ANOVA analysis. Descriptive
statistics regarding the frequency distributions, as well as all
other tests described above, were done using SAS-PC (SAS
Institute Inc, Cary, NC).
3. Results
3.1. BLV Index. A total of 4,300 milk samples were collected
from all 113 herds, from an average of 9.6 ± 0.1, 9.7 ± 0.1,
9.5±0.1, and 9.2±0.1 cows each from the 1st, 2nd, 3rd, and
≥4th lactations, respectively. Mean days in milk of all tested
animals was 79.2 ± 0.7 days, with a median of 66 days and
range of 8 to 357 days. The mean days in milk at the time
of sampling for lactations 1, 2, 3, and ≥4, were 65.9 ± 0.9,
70.5 ± 1.1, 89.3 ± 1.5, and 91.0 ± 1.6 days, respectively. The
mean BHP for all herds was 32.8 ± 2.1 (median of 30.0,
range 0 to 80.6; Figure 1). The mean percent of 1st, 2nd,
3rd, and ≥4th lactation animals infected was 18.5 ± 2.0,
28.8 ±2.6, 39.1 ±2.8, and 44.8 ±2.8, respectively (Figure 2),
and diﬀered signiﬁcantly (P<0.0001 by one-way ANOVA)
with or without the assumption of equal variance among
the 4 lactation groups. For the eight herds in which all
lactating cattle were sampled and tested for BLV by ELISA,
the BHP was found to be highly correlated with the actual
ELISA prevalence (r = 0.994, P<0.0001), and also highly
correlated with the average lactation prevalence (r = 0.995,
P<0.0001; Figure 3).
4. Discussion
ELISA testing of milk for BLV antigens has been proposed
as a dependable method to determine infection status [8].
We chose milk ELISA as an attractive method to coordinateVeterinary Medicine International 3
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Figure 1: Frequency distribution of Bovine Leukemia Virus herd
proﬁle (BHP) for 113 dairy herds in Michigan. For each herd, the
percent of cows that tested Bovine Leukemia Virus (BLV) positive
within the ﬁrst, second, third, and fourth or greater lactations
(ten cows from each lactation) was averaged to calculate the BHP.
The 25th, 50th, and 75th percentiles were 14.6, 30.0, and 48.9,
respectively.
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Figure 2: Mean prevalence, by lactation, of cows from 113 dairy
herds that were positive for Bovine Leukemia Virus (BLV) by milk
ELISA. For the null hypothesis that the true population correlation
coeﬃcient is zero, analysis of variance was signiﬁcant (P<0.0001).
large-scale herd surveillance because sample collection dur-
ing DHIA testing requires little additional labor input and
is more cost-eﬀective than serum testing. In a preliminary
phase of the study, we compared the ability to detect BLV
antibodies by ELISA in milk as compared to serum in 142
cows from two herds (76 and 66 cows from each herd, resp.).
Of the 57 serum positive cows, 49 were also milk positive
(sensitivity = 86%). All 85 serum negative samples also
tested negative in milk (speciﬁcity = 100%). Thus, although
detecting BLV antibodies by milk ELISA was not as sensitive
serumELISA,theoverallagreementbetweentestswas>94%.
Because of potential variation in BLV antibody titers in the
immediate periparturient period [9], and in order to facili-
tate identiﬁcation of enrolled cows by DHIA technicians, the
second test date after calving was our targeted population
of cows for sampling. We were able to sample 75% of the
cows in our study by 100 days in milk, and 90% by 150
days in milk. The mean days in milk for sample collection
from each cow increased with increasing lactation. This was
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Figure 3: Bovine Leukemia Virus herd proﬁle (BHP) by testing 40
milking cows (ten from each of the ﬁrst, second, third and fourth or
greater lactations), for Bovine Leukemia Virus (BLV) as compared
to testing all milking cows in the herd and calculating either: (1) the
actual BLV prevalence (solid line-) as measured by the number
of BLV positive cows divided by the total number tested, or (2)
a lactation-speciﬁc BLV proﬁle (dashed line-), calculated as an
average of the percent of BLV infected cows in each of the four
lactationgroups.ThecorrelationbetweentheactualBLVprevalence
and BHP was 0.988 (P = 0.0016), and the total herd proﬁle and
BHP was 0.995 (P = 0.0005).
likely due to attrition in older cows, which resulted in greater
dispersal in the stage of lactation to acquire the necessary
number of cows for the BHP herd proﬁle. Further variation
in days in milk at the time of sampling was caused by a small
number of herds that tested every two weeks, or less fre-
quently than monthly, and suspected cohorts of animals that
calved in groups as a consequence of estrous synchroniza-
tion. More consistency in stage of lactation at the time of
sampling was generally obtained as herd size increased. Con-
cernoveradditionalsamplevariationsrelativetodaysinmilk
was our primary reason for excluding smaller herds.
The correlation between the BHP and the actual preva-
lence of BLV-positive cows in eight herds of diverse size and
prevalence was excellent. Thus, our study suggests that the
BHP provides a practical and representative herd proﬁle that
enables comparisons of BLV prevalence among herds. Addi-
tionally, by sampling the 10 most recently calved-cows, the
BHP enables dairy producers to determine if heifers entering
the milking herd are already BLV-positive, suggesting trans-
mission factors speciﬁc to heifer-raising practices.
At the cow level, BLV prevalence is positively associated
with lactation number (Figure 2). It is probable that age is
both a cause and an eﬀect of BLV infection. As such, it is
diﬃcult to make fair comparisons among herds with diﬀer-
ent age distributions or to monitor BLV within a herd which
has a changing age distribution. By virtue of the sampling
scheme within each of four lactation groups, the advantage
oftheBHPisthatitisuninﬂuencedbydiﬀerencesorchanges
in the herd age distribution.
In our study, BLV prevalence was higher in older cattle.
Thisparallelsearlierreportsofahigherincidenceoflympho-
sarcoma, and positive serology, in older as compared to4 Veterinary Medicine International
younger cattle [6, 7, 10] .Am o r er e c e n ts t u d y ,u s i n gs e r u m
PCR in a dairy herd with a high prevalence of infection
(85%), determined that 11%, 15%, and 24% of newborn
calves, breeding age heifers, and 27-month-old cows were
BLV positive, respectively [11]. Additionally, 61% of animals
were infected by 36 months of age. Higher proportions
of BLV seroconversion in older animals may result from
longer age-associated duration of exposure to risk factors
associated with the transmission of this disease, for example,
use of common needles, palpation sleeves, and close contact
between infected and noninfected animals [10]. However, if
the ability to detect the presence of BLV in cattle by ELISA
testing is limited relative to actual viral load, part of the age-
associated increase in antibody prevalence, as observed in
ourandotherstudies,maybeduetopreexistingseronegative
infections in younger cows that later seroconvert to positive
status, rather than from a recent exposure to the BLV virus.
This concept is refuted by previous studies of experimental
BLV infections that determined serologic conversion to BLV-
positive status that occurred within 3 to 14 weeks after
inoculation [12–14]. However, experimental infections may
not account for genetic diversity of the virus or the wide
range of encountered infectious particles, that is, exposure
dose, experienced during natural challenge. Several reports
have identiﬁed the existence of persistently BLV-infected, as
determined by PCR, but seronegative animals [15–17]. Fur-
thermore,real-timeqPCRmaybemoresensitiveindetecting
BLV proviral load in infected cattle than previously reported
nested-PCR protocols [18]. If an economical method of
testing for BLV by PCR can be employed in milk samples,
this may provide an alternative to ELISA.
5. Conclusions
Overall, mean BLV prevalence of infection increased as the
number of lactations increased, which likely arises from
complex interactions among herd management, pathogen
exposure, and possible limitations to detect all infected
animals by routine screening with milk ELISA. The use of
milk ELISA, coupled with employment of the BHP, enables
a practical tool to determine age-stratiﬁed prevalence of
BLV infection in dairy herds. We propose the BHP as a
standard to help dairy producers manage BLV infection
within their herds because the BHP (1) indicates which
age groups are becoming infected, thereby suggesting which
disease control interventions may be most eﬀective, (2)
provides a means to monitor the impact of disease control
interventions, (3) allows comparisons with other herds, or
historical comparisons within the same herd, regardless of
diﬀerences in age distribution, and (4) is highly correlated
(r = 0.99) with crude herd BLV prevalence.
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